ATORVASTATIN SANDOZ atorvastatin 40 mg film-coated tablet bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

atorvastatin calcium trihydrate, Quantity: 43.3 mg

Available from:

Sandoz Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: polysorbate 80; microcrystalline cellulose; magnesium stearate; hyprolose; croscarmellose sodium; lactose monohydrate; calcium carbonate; titanium dioxide; hypromellose; macrogol 6000

Administration route:

Oral

Units in package:

100 (dispensing use only)

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Atorvastatin Sandoz is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia. Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemia, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated.,Atorvastatin Sandoz is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD to reduce the risk of non-fatal myocardial infarction (MI) and non-fatal stroke.,These effects do not replace the need to independently control known causes of cardiovascular (CV) mortality and morbidity such as hypertension, diabetes and smoking

Product summary:

Visual Identification: White to off-white, round, biconvex film coated tablet debossed with A40 on one side, and cross scored breaking notch on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 16 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

2020-12-10